Outcomes of Older Adults with Non-Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplantation: A Mayo Clinic Cohort Analysis-Reference-Cited by-同舟云学术

Outcomes of Older Adults with Non-Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplantation: A Mayo Clinic Cohort Analysis

Published:2023-03 Issue:3 Volume:29 Page:176.e1-176.e8
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Wudhikarn Kitsada^ORCID,Johnson Bradley M.,Inwards David J.^ORCID,Porrata Luis F.,Micallef Ivana N.,Ansell Stephen M.^ORCID,Hogan Willam J.,Paludo Jonas^ORCID,Villasboas Jose C.,Johnston Patrick B.

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference29 articles.

1. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma;Philip;N Engl J Med,1995

2. Autologous stem cell transplantation in the management of relapsed non-Hodgkin lymphoma;Alencar;J Clin Oncol,2021

3. How we approach patient evaluation for hematopoietic stem cell transplantation;Hamadani;Bone Marrow Transplant,2010

4. High-dose chemotherapy and autologous stem cell transplant in older patients with lymphoma;Lahoud;Curr Oncol Rep,2015

5. Current use of and trends in hematopoietic cell transplantation in the United States;D'Souza;Biol Blood Marrow Transplant,2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autologous Stem Cell Transplant in Fit Patients With Late Relapsed Diffuse Large B-Cell Lymphoma That Responded to Salvage Chemotherapy;Transplantation and Cellular Therapy;2024-07

2. Appropriate Treatment Intensity for Diffuse Large B-Cell Lymphoma in the Older Population: A Review of the Literature;Hematology Reports;2024-05-24

3. Autologous stem cell transplant in fit patients with refractory or early relapsed diffuse large B-cell lymphoma that responded to salvage chemotherapy;Haematologica;2024-01-18